10-Year Follow-Up: Pembrolizumab Outshines Ipilimumab in Advanced Melanoma
Long-term study shows pembrolizumab's superior efficacy over ipilimumab for advanced melanoma patients.
Acute Myeloid Leukemia
4 articles
New Hope for Acute Myeloid Leukemia: Cusatuzumab Shows Promise in Clinical Trial
Cusatuzumab plus azacitidine shows efficacy in treating newly diagnosed acute myeloid leukemia
Decitabine vs. Standard Chemo: A New Approach for Older AML Patients
Study compares 10-day decitabine to standard chemo for older AML patients eligible for transplant
Fosfomycin vs Ciprofloxacin: A New Approach to Prevent Infections in High-Risk Blood Cancer Patients
Study compares fosfomycin to ciprofloxacin for preventing infections in leukemia and transplant patients
New Combination Therapy Shows Promise for Relapsed/Refractory AML
Study evaluates quizartinib plus chemotherapy for relapsed/refractory acute myeloid leukemia with FLT3 mutations